Literature DB >> 9000317

Meta-analysis of brain and cranial size in schizophrenia.

K E Ward1, L Friedman, A Wise, S C Schulz.   

Abstract

Several meta-analyses are presented that address the issue of brain and/or cranial size reductions in schizophrenia. Separate meta-analyses were conducted for brain size (n = 27 studies), intracranial size (n = 18) or extracranial size (n = 8). For each meta-analysis, the weighted composite effect size (d) was tested for statistical significance (the direction of the effect size was negative if patients with schizophrenia had smaller structure size than controls). The influence of several potential modifiers of effect size (age, methods, region, gender) was individually evaluated. The composite effect sizes for studies of brain, intracranial and extracranial measures were d = -0.26, (p < 0.0001), d = -0.18, (p = 0.0012), and d = +0.14, (p = 0.16), respectively. Thus, the review found evidence for a small, but statistically significant reduction in brain and intracranial size in schizophrenia, but no evidence for a reduction in extracranial size. Studies based on axial image slices had significantly larger effects (d = -0.60) than the studies based on sagittal images (d = -0.09) (chi(2) = 14.0, p = 0.0002). In summary, the findings clearly support a small yet highly significant reduction of brain and intracranial size in schizophrenia.

Entities:  

Mesh:

Year:  1996        PMID: 9000317     DOI: 10.1016/s0920-9964(96)00076-x

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  39 in total

1.  Volumetric magnetic resonance imaging study of the brain in subjects with sex chromosome aneuploidies.

Authors:  M M Warwick; G A Doody; S M Lawrie; J N Kestelman; J J Best; E C Johnstone
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

2.  ASPM regulates Wnt signaling pathway activity in the developing brain.

Authors:  Joshua J Buchman; Omer Durak; Li-Huei Tsai
Journal:  Genes Dev       Date:  2011-09-15       Impact factor: 11.361

Review 3.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

Review 4.  Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?

Authors:  Konasale M Prasad; Matcheri S Keshavan
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

5.  Parental age effects on cortical morphology in offspring.

Authors:  P Shaw; M Gilliam; M Malek; N Rodriguez; D Greenstein; L Clasen; A Evans; J Rapoport; J Giedd
Journal:  Cereb Cortex       Date:  2011-08-04       Impact factor: 5.357

6.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

7.  Height, weight and body mass index (BMI) in psychiatrically ill US Armed Forces personnel.

Authors:  R J Wyatt; I D Henter; R Mojtabai; J J Bartko
Journal:  Psychol Med       Date:  2003-02       Impact factor: 7.723

8.  Study of childhood onset schizophrenia (COS) using SPECT and neuropsychological assessment.

Authors:  Savita Malhotra; Nitin Gupta; Anish Bhattacharya; Mehak Kapoor
Journal:  Indian J Psychiatry       Date:  2006-10       Impact factor: 1.759

9.  Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects.

Authors:  Sander V Haijma; Neeltje Van Haren; Wiepke Cahn; P Cédric M P Koolschijn; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Schizophr Bull       Date:  2012-10-05       Impact factor: 9.306

10.  Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis.

Authors:  Yi-Huei Linda Jen; Michele Musacchio; Arthur D Lander
Journal:  Neural Dev       Date:  2009-09-04       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.